CN Patent
CN116444529B — 一种氘代氮杂环丁烷类jak抑制剂及其用途
Assigned to Henan Yaokang Zhongtuo Pharmaceutical Technology Co ltd · Expires 2023-12-05 · 2y expired
What this patent protects
本发明公开了一种氘代氮杂环丁烷JAK抑制剂,如下式Ⅰ所示,本发明涉及氘代氮杂环丁烷JAK抑制剂、其药物组合物及用途。
USPTO Abstract
本发明公开了一种氘代氮杂环丁烷JAK抑制剂,如下式Ⅰ所示,本发明涉及氘代氮杂环丁烷JAK抑制剂、其药物组合物及用途。
Drugs covered by this patent
- Olumiant (baricitinib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.